ResMed Inc (RMD)
243.60
+2.05
(+0.85%)
USD |
NYSE |
Nov 21, 16:00
244.95
+1.35
(+0.55%)
Pre-Market: 20:00
ResMed Total Assets (Quarterly): 7.222B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 7.222B |
June 30, 2024 | 6.872B |
March 31, 2024 | 6.815B |
December 31, 2023 | 6.905B |
September 30, 2023 | 6.741B |
June 30, 2023 | 6.752B |
March 31, 2023 | 6.714B |
December 31, 2022 | 6.676B |
September 30, 2022 | 5.178B |
June 30, 2022 | 5.096B |
March 31, 2022 | 4.905B |
December 31, 2021 | 4.735B |
September 30, 2021 | 4.729B |
June 30, 2021 | 4.728B |
March 31, 2021 | 4.586B |
December 31, 2020 | 4.573B |
September 30, 2020 | 4.621B |
June 30, 2020 | 4.587B |
March 31, 2020 | 4.511B |
December 31, 2019 | 4.354B |
September 30, 2019 | 4.155B |
June 30, 2019 | 4.108B |
March 31, 2019 | 4.099B |
December 31, 2018 | 3.860B |
September 30, 2018 | 3.068B |
Date | Value |
---|---|
June 30, 2018 | 3.064B |
March 31, 2018 | 3.534B |
December 31, 2017 | 3.564B |
September 30, 2017 | 3.490B |
June 30, 2017 | 3.468B |
March 31, 2017 | 3.423B |
December 31, 2016 | 3.323B |
September 30, 2016 | 3.322B |
June 30, 2016 | 3.257B |
March 31, 2016 | 2.445B |
December 31, 2015 | 2.239B |
September 30, 2015 | 2.255B |
June 30, 2015 | 2.182B |
March 31, 2015 | 2.278B |
December 31, 2014 | 2.327B |
September 30, 2014 | 2.309B |
June 30, 2014 | 2.361B |
March 31, 2014 | 2.365B |
December 31, 2013 | 2.346B |
September 30, 2013 | 2.335B |
June 30, 2013 | 2.211B |
March 31, 2013 | 2.375B |
December 31, 2012 | 2.330B |
September 30, 2012 | 2.245B |
June 30, 2012 | 2.138B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.354B
Minimum
Dec 2019
7.222B
Maximum
Sep 2024
5.565B
Average
5.001B
Median
Total Assets (Quarterly) Benchmarks
Boston Scientific Corp | 38.08B |
Globus Medical Inc | 5.086B |
Abbott Laboratories | 74.36B |
Haemonetics Corp | 2.525B |
Becton Dickinson & Co | 57.29B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.027B |
Shareholders Equity (Quarterly) | 5.195B |
Debt to Equity Ratio | 0.1304 |
Current Ratio | 2.921 |
Net Debt Paydown Yield | 0.43% |